CT SB00162 | 2024 | General Assembly
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 21 2024 - 25% progression, died in committee
Action: 2024-02-21 - Referred to Joint Committee on Finance, Revenue and Bonding
Pending: Joint Finance, Revenue and Bonding Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 21 2024 - 25% progression, died in committee
Action: 2024-02-21 - Referred to Joint Committee on Finance, Revenue and Bonding
Pending: Joint Finance, Revenue and Bonding Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To offer tax incentives to pharmaceutical manufacturers and sterile compounding pharmacies that manufacture and compound essential drugs in this state.
Title
An Act Establishing Tax Incentives To Support Prescription Drug Compounding.
Sponsors
| Sen. Saud Anwar [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-21 | Senate | Referred to Joint Committee on Finance, Revenue and Bonding |
Connecticut State Sources
| Type | Source |
|---|---|
| Summary | https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=SB00162&which_year=2024 |
| Text | https://www.cga.ct.gov/2024/TOB/S/PDF/2024SB-00162-R00-SB.PDF |
